loadpatents
Patent applications and USPTO patent grants for Beta Cat Pharmaceuticals, LLC.The latest application filed is for "methods for treatment of diseases and disorders related to transducin beta-like protein 1 (tbl1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia.".
Patent | Date |
---|---|
Methods for treatment of diseases and disorders related to transducin .beta.-like protein 1 (TBL1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia Grant 9,238,030 - Bhalla , et al. January 19, 2 | 2016-01-19 |
Methods for treatment of diseases and disorders related to transducin beta-like protein 1 (TBL1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia. App 20130143920 - Bhalla; Kapil N. ;   et al. | 2013-06-06 |
Compositions and Methods for Inhibition of TBL-1 Binding to Disease-Associated Molecules App 20130123281 - Vankayalapati; Hariprasad M. ;   et al. | 2013-05-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.